{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:13:54Z","timestamp":1792602834568,"version":"4.5.0"},"reference-count":100,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2019,10,24]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Cancer is one of the most life-threatening diseases worldwide. Since inflammation is\nconsidered to be one of the known characteristics of cancer, the activity of PGE2 has been paired with different\ntumorigenic steps such as increased tumor cell proliferation, resistance to apoptosis, increased invasiveness,\nangiogenesis and immunosuppression.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> It has been successfully demonstrated that inhibition of mPGES-1 prevented inflammation in preclinical\nstudies. However, despite the crucial roles of mPGEs-1 and PGE2 in tumorigenesis, there is not much in vivo study\non mPGES-1 inhibition in cancer therapy. The specificity of mPGEs-1 enzyme and its low expression level under\nnormal conditions makes it a promising drug target with a low risk of side effects.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A comprehensive literature search was performed for writing this review. An updated view on PGE2\nbiosynthesis, PGES isoenzyme family and its pharmacology and the latest information about inhibitors of mPGES-1\nhave been discussed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In this study, it was aimed to highlight the importance of mPGES-1 and its inhibition in inflammationrelated\ncancer and other inflammatory conditions. Information about PGE2 biosynthesis, its role in inflammationrelated\npathologies were also provided. We kept the noncancer-related inflammatory part short and tried to bring\ntogether promising molecules or scaffolds.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The information provided in this review might be useful to researchers in designing novel and potent\nmPGES-1 inhibitors for the treatment of cancer and inflammation.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520619666190227174137","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T12:03:15Z","timestamp":1551700995000},"page":"1205-1222","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Microsomal Prostaglandin E2 Synthase-1 as a New Macromolecular Drug Target in the Prevention of Inflammation and Cancer"],"prefix":"10.2174","volume":"19","author":[{"given":"Bahad\u0131r","family":"B\u00fclb\u00fcl","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lkay","family":"K\u00fc\u00e7\u00fckg\u00fczel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2013.08.018","volume":"69","author":"Panathur N.","year":"2013","unstructured":"Panathur N.; Dalimba U.; Koushik P.V.; Alvala M.; Yogeeswari P.; Sriram D.; Kumar V.; Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition. Eur J Med Chem 2013,69,125-138","journal-title":"Eur J Med Chem"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejmech.2016.05.017","volume":"121","author":"Kulaba\u015f N.","year":"2016","unstructured":"Kulaba\u015f N.; Tatar E.; \u00d6zakp\u0131nar \u00d6.B.; \u00d6zsavc\u0131 D.; Pannecouque C.; Clercq E.D.; K\u00fc\u00e7\u00fckg\u00fczel \u0130.; Synthesis and antiproliferative evaluation of novel 2-(4H-1,2,4-triazole-3-ylthio)acetamide derivatives as inducers of apoptosis in cancer cells. Eur J Med Chem 2016,121,58-70","journal-title":"Eur J Med Chem"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.lfs.2014.07.042","volume":"116","author":"Ruan D.","year":"2014","unstructured":"Ruan D.; So D.R.; Prostaglandin E produced by inducable COX-2 and mPGEs-1 promoting cancer cell proliferation in vitro and in vivo. Life Sci 2014,116(1),43-50","journal-title":"Life Sci"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1074\/jbc.M006865200","volume":"276","author":"Mancini J.A.","year":"2001","unstructured":"Mancini J.A.; Blood K.; Guay J.; Gordon R.; Claveau D.; Chan C.C.; Riendeau D.; Cloning, expression, and up-regulation of inducible rat prostaglandin E synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis. J Biol Chem 2001,276(9),4469-4475","journal-title":"J Biol Chem"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1538\/expanim.60.7","volume":"60","author":"Murakami M.","year":"2011","unstructured":"Murakami M.; Lipid mediators in life science. Exp Anim 2011,60(1),7-20","journal-title":"Exp Anim"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.biochi.2010.02.006","volume":"92","author":"Nakanishi M.","year":"2010","unstructured":"Nakanishi M.; Gokhale V.; Meuillet E.J.; Rosenberg D.W.; mPGEs-1 as a target for cancer suppression, a comrehensive invited review \u201cPhospholipase A and Lipid Mediators\u201d. Biochimie 2010,92(6),660-664","journal-title":"Biochimie"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1440-1789.2008.00963.x","volume":"29","author":"Mattila S.","year":"2009","unstructured":"Mattila S.; Tuominen H.; Koivukangas J.; Stenback F.; The terminal prostaglandin synthases mPGEs-1, mPGEs-2 and cPGEs are all overexpressed in human gliomas. Neuropathology 2009,29(2),156-165","journal-title":"Neuropathology"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.prostaglandins.2015.06.002","volume":"120","author":"Larsson K.","year":"2015","unstructured":"Larsson K.; Jakobsson P.J.; Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment. Prostaglandins Other Lipid Mediat 2015,120,161-165","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1073\/pnas.0910218106","volume":"106","author":"Hanaka H.","year":"2009","unstructured":"Hanaka H.; Pawelzik S.C.; Johnsen J.I.; Rakonjac M.; Terawaki K.; Rasmuson A.; Sveinbj\u00f6rnsson B.; Schumacher M.C.; Hamberg M.; Samuelsson B.; Jakobsson P.J.; Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells. Proc Natl Acad Sci USA 2009,106(44),18757-18762","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.molmed.2012.02.002","volume":"18","author":"Salvado M.D.","year":"2012","unstructured":"Salvado M.D.; Alfranca A.; Haeggstr\u00f6m J.Z.; Redondo J.M.; Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2. Trends Mol Med 2012,18(4),233-243","journal-title":"Trends Mol Med"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"Ricciotti E.","year":"2011","unstructured":"Ricciotti E.; FitzGerald G.A.; Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011,31(5),986-1000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drudis.2016.08.003","volume":"22","author":"Markovic T.","year":"2017","unstructured":"Markovic T.; Jakopin Z.; Dolenc M.S.; Rascan I.M.; Structural features of subtype-selective EP receptor modulators. Drug Discov Today 2017,22(1),57-71","journal-title":"Drug Discov Today"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bcp.2018.10.007","volume":"158","author":"Sala A.","year":"2018","unstructured":"Sala A.; Proschakc E.; Steinhilberc D.; Rovatia E.; Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade. Biochem Pharmacol 2018,158,161-173","journal-title":"Biochem Pharmacol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.06.022","volume":"98","author":"Koeberle A.","year":"2015","unstructured":"Koeberle A.; Werz O.; Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders. Biochem Pharmacol 2015,98(1),1-15","journal-title":"Biochem Pharmacol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tips.2012.02.004","volume":"33","author":"Aoki T.","year":"2012","unstructured":"Aoki T.; Narumiya S.; Prostaglandins and chronic inflammation. Trends Pharmacol Sci 2012,33(6),304-311","journal-title":"Trends Pharmacol Sci"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1073\/pnas.96.13.7220","volume":"96","author":"Jakobsson P.J.","year":"1999","unstructured":"Jakobsson P.J.; Thoren S.; Morgenstern R.; Samuelsson B.; Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 1999,96(13),7220-7225","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1021\/jm800197b","volume":"51","author":"Friesen R.W.","year":"2008","unstructured":"Friesen R.W.; Mancini J.A.; Microsomal prostaglandin E2 synthase-1 (MPGES-1): A novel therapotic Target. J Med Chem 2008,51(14),4059-4067","journal-title":"J Med Chem"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4155\/fmc.11.136","volume":"3","author":"Chang H.H.","year":"2011","unstructured":"Chang H.H.; Meuillet E.J.; Identification and development of mPGEs-1 inhibitors: Where we are at? Future Med Chem 2011,3(15),1909-1934","journal-title":"Future Med Chem"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.prostaglandins.2013.07.004","volume":"107","author":"Idborg H.","year":"2013","unstructured":"Idborg H.; Olsson P.; Leclerc P.; Raouf J.; Jakobsson P.J.; Korotkova M.; Effects of mPGEs-1 deletion on eicosanoid and fatty acid profiles in mice. Prostaglandins Other Lipid Mediat 2013,107,18-25","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1021\/acs.jmedchem.5b01750","volume":"59","author":"Koeberle A.","year":"2016","unstructured":"Koeberle A.; Laufer S.A.; Werz O.; Design and development of microsomal prostaglandin e2 synthase-1 \u0131nhibitors: Challenges and future directions. J Med Chem 2016,59(13),5970-5986","journal-title":"J Med Chem"},{"key":"ref=21","first-page":"1","volume":"11","author":"Gurpinar E.","year":"2013","unstructured":"Gurpinar E.; Grizzle W.E.; Piazza G.A.; COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs. Front Oncol 2013,11(3),1-18","journal-title":"Front Oncol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.drudis.2015.12.003","volume":"21","author":"Regulski M.","year":"2016","unstructured":"Regulski M.; Regulska K.; Pruka\u0142a W.; Piotrowska H.; Stanisz B.; Murias M.; COX-2 inhibitors: A novel strategy in the management of breast cancer. Drug Discov Today 2016,21(4),598-615","journal-title":"Drug Discov Today"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/j.ejmech.2009.03.044","volume":"44","author":"Sujith K.V.","year":"2009","unstructured":"Sujith K.V.; Rao J.N.; Shetty P.; Kalluraya B.; Regioselective reaction: Synthesis and pharmacological study of Mannich bases containing ibuprofen moiety. Eur J Med Chem 2009,44(9),3697-3702","journal-title":"Eur J Med Chem"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1016\/j.bmcl.2016.08.023","volume":"26","author":"Kuklish S.L.","year":"2016","unstructured":"Kuklish S.L.; Antonysamy S.; Bhattachar S.N.; Chandrasekhar S.; Fisher M.J.; Fretland A.J.; Gooding K.; Harvey A.; Hughes N.E.; Luz J.G.; Manninen P.R.; McGee J.E.; Navarro A.; Norman B.H.; Partridge K.M.; Quimby S.J.; Schiffler M.A.; Sloan A.V.; Warshawsky A.M.; York J.S.; Yu X.P.; Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors. Bioorg Med Chem Lett 2016,26(19),4824-4828","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1021\/acs.biochem.5b00339","volume":"54","author":"Akasaka H.","year":"2015","unstructured":"Akasaka H.; So S.P.; Ruan K.H.; Relationship of the topological distances and activities between mPGEs-1 and COX-2 versus COX-1: Implications of the different post-translational endoplasmic reticulum organizations of COX-1 and COX-2. Biochemistry 2015,54(23),3707-3715","journal-title":"Biochemistry"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.abb.2016.04.011","volume":"603","author":"Akasaka H.","year":"2016","unstructured":"Akasaka H.; Ruan K.H.; Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGEs-1. Arch Biochem Biophys 2016,603,29-37","journal-title":"Arch Biochem Biophys"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1021\/jm301900x","volume":"56","author":"He S.","year":"2013","unstructured":"He S.; Li C.; Liu Y.; Lai L.; Discovery of highly potent microsomal prostaglandin E2 synthase 1 inhibitors using the active conformation structural model and virtual screen. J Med Chem 2013,56(8),3296-3309","journal-title":"J Med Chem"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.gene.2013.05.069","volume":"527","author":"Lee A.S.","year":"2013","unstructured":"Lee A.S.; Ellman M.B.; Yan D.; Kroin J.S.; Cole B.J.; Wijnen A.J.V.; Im, H.J. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene 2013,527(2),440-447","journal-title":"Gene"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/BJ20110977","volume":"440","author":"He S.","year":"2011","unstructured":"He S.; Wu Y.; Yu D.; Lai L.; Microsomal prostaglandin E synthase-1 exhibits one-third-of-the-sites reactivity. Biochem J 2011,440(1),13-21","journal-title":"Biochem J"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/labinvest.3700200","volume":"85","author":"Gudis K.","year":"2005","unstructured":"Gudis K.; Tatsuguchi A.; Wada K.; Futagami S.; Nagata K.; Hiratsuka T.; Shinji Y.; Miyake K.; Tsukui T.; Fukuda Y.; Sakamoto C.; Microsomal prostaglandin e synthase (MPGES-1), mPGEs-2 ve cytosolic PGES expression in human gastritis and gastric ulcer tissue. Lab Invest 2005,85(2),225-236","journal-title":"Lab Invest"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jalz.2007.10.015","volume":"4","author":"Chaudhry U.A.","year":"2008","unstructured":"Chaudhry U.A.; Zhuang H.; Crain B.J.; Dor\u00e9 S.; Elevated microsomal prostaglandin-E synthase-1 in Alzheimer\u2019s disease. Alzheimers Dement 2008,4(1),6-13","journal-title":"Alzheimers Dement"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2010.00146","volume":"1","author":"Korotkova M.","year":"2011","unstructured":"Korotkova M.; Jakobsson P.J.; Microsomal prostaglandin E synthase-1 in rheumatic diseases. Front Pharmacol 2011,1,1-8","journal-title":"Front Pharmacol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"32783","DOI":"10.1074\/jbc.M003505200","volume":"275","author":"Murakami M.","year":"2000","unstructured":"Murakami M.; Naraba H.; Tanioka T.; Semmyo N.; Nakatani Y.; Kojima F.; Ikeda T.; Fueki M.; Ueno A.; Ohishi S.; Kudo I.; Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000,275(42),32783-32792","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17765-5","volume":"8","author":"Ding K.","year":"2018","unstructured":"Ding K.; Zhou Z.; Hou S.; Yuan Y.; Zhou S.; Zheng X.; Chen J.; Loftin C.; Zheng F.; Zhan C.G.; Structure-based discovery of mPGEs-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of antiinflammatory drugs. Sci Rep 2018,8(1),1-9","journal-title":"Sci Rep"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1472-8206.2005.00316.x","volume":"19","author":"Kojima F.","year":"2005","unstructured":"Kojima F.; Kato S.; Kawai S.; Prostaglandin E synthase in the pathophysiology of arthritis. Fundam Clin Pharmacol 2005,19(3),255-261","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jhep.2014.07.018","volume":"61","author":"Sun Y.","year":"2014","unstructured":"Sun Y.; Jia Z.; Yang G.; Kakizoe Y.; Liu M.; Yang K.T.; Liu Y.; Yang B.; Yang T.; Microsomal PGEs-2 deletion remarkably enhances liver injury in streptozotocin-treated mice via induction of GLUT2. J Hepatol 2014,61(6),1328-1336","journal-title":"J Hepatol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1021\/bi700605m","volume":"46","author":"Yamada T.","year":"2007","unstructured":"Yamada T.; Takusagawa F.; PGH Degradation pathway catalyzed by GSH-heme complex bound microsomal prostaglandin E2 synthase type 2: The first example of a dual-function enzyme. Biochemistry 2007,46(28),8414-8424","journal-title":"Biochemistry"},{"key":"ref=38","first-page":"3971","volume":"7","author":"Yoshimatsu K.","year":"2001","unstructured":"Yoshimatsu K.; Golijanin D.; Paty P.B.; Soslow R.A.; Jakobsson P.J.; DeLellis R.A.; Subbaramaiah K.; Dannenberg A.J.; Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin Cancer Res 2001,7(12),3971-3976","journal-title":"Clin Cancer Res"},{"key":"ref=39","first-page":"2669","volume":"7","author":"Yoshimatsu K.","year":"2001","unstructured":"Yoshimatsu K.; Altorki N.K.; Golijanin D.; Zhang F.; Jakobsson P.J.; Dannenberg A.J.; Subbaramaiah K.; Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin Cancer Res 2001,7(9),2669-2674","journal-title":"Clin Cancer Res"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2015.10.008","volume":"142","author":"Matsuda H.","year":"2015","unstructured":"Matsuda H.; Hosono K.; Tsuru S.; Kurashige C.; Sekiguchi K.; Akira S.; Uematsu S.; Okamoto H.; Majima M.; Roles of mPGES-1, an inducible prostaglandin E synthase, in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model. Life Sci 2015,142,1-7","journal-title":"Life Sci"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.biopha.2010.12.008","volume":"65","author":"Numao A.","year":"2011","unstructured":"Numao A.; Hosono K.; Suzuki T.; Hayashi I.; Uematsu S.; Akira S.; Ogino Y.; Kawauchi H.; Unno N.; Majima M.; The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model. Biomed Pharmacother 2011,65(1),77-84","journal-title":"Biomed Pharmacother"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-07-6100","volume":"68","author":"Nakanishi M.","year":"2008","unstructured":"Nakanishi M.; Montrose D.C.; Clark P.; Nambiar P.R.; Belinsky G.S.; Claffey K.P.; Xu D.; Rosenberg D.W.; Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res 2008,68(9),3251-3259","journal-title":"Cancer Res"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.humpath.2007.04.020","volume":"38","author":"Gudis K.","year":"2007","unstructured":"Gudis K.; Tatsuguchi A.; Wada K.; Hiratsuko T.; Futagami S.; Fukuda Y.; Kiyama T.; Tajiri T.; Miyake K.; Sakamoto C.; Clinical significance of prostaglandin E synthase expression in gastric cancer tissue. Hum Pathol 2007,38(12),1826-1835","journal-title":"Hum Pathol"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"42-45","DOI":"10.1016\/j.prostaglandins.2015.06.006","volume":"121","author":"Sasaki Y.","year":"2015","unstructured":"Sasaki Y.; Nakatani Y.; Hara S.; Role of microsomal\nprostaglandin E synthase-1- (MPGES-1)-derived prostaglandin E2\nin kolon carcinogenesis. Prostagland Other Lipid Mediat 2015,121(A),42-45","journal-title":"Prostagland Other Lipid Mediat"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/JTO.0b013e3181e2f4f5","volume":"5","author":"Wu Y.C.","year":"2010","unstructured":"Wu Y.C.; Su L.J.; Wang H.W.; Lin C.F.J.; Hsu W.H.; Chou T.Y.; Huang C.Y.F.; Lu C.L.; Hsueh C.T.; Co-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancer. J Thorac Oncol 2010,5(8),1167-1174","journal-title":"J Thorac Oncol"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1158\/0008-5472.CAN-07-6689","volume":"68","author":"Jain S.","year":"2008","unstructured":"Jain S.; Chakraborty G.; Raja R.; Kale S.; Kundu G.C.; Prostaglandin E regulates tumor angiogenesis in prostate cancer. Cancer Res 2008,68(19),7750-7759","journal-title":"Cancer Res"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bcpt.12162","volume":"114","author":"Korotkova M.","year":"2014","unstructured":"Korotkova M.; Jakobsson P.J.; Characterization of microsomal prostaglandin E Synthase 1 inhibitors. Basic Clin Pharmacol Toxicol 2014,114,64-69","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1038\/onc.2011.503","volume":"31","author":"Donnini S.","year":"2012","unstructured":"Donnini S.; Finetti F.; Terzuoli E.; Giachetti A.; Iniguez M.A.; Hanaka H.; Fresno M.; Radmark O.; Ziche M.; EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity. Oncogene 2012,31,3457-3466","journal-title":"Oncogene"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/ERC-15-0277","volume":"22","author":"Finetti F.","year":"2015","unstructured":"Finetti F.; Terzuoli E.; Giachetti A.; Santi R.; Villari D.; Hanaka H.; Radmark O.; Ziche M.; Donnini S.; mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity. Endocr Relat Cancer 2015,22(4),665-678","journal-title":"Endocr Relat Cancer"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1248\/bpb.b16-01026","volume":"40","author":"Matsuo Y.I.","year":"2017","unstructured":"Matsuo Y.I.; The role of mPGES-1 in inflammatory brain diseases. Biol Pharm Bull 2017,40(5),557-563","journal-title":"Biol Pharm Bull"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drudis.2016.09.017","volume":"22","author":"Qiu J.","year":"2017","unstructured":"Qiu J.; Shi Z.; Jiang J.; Cyclooxygenase-2 in glioblastoma multiforme. Drug Discov Today 2017,22(1),148-156","journal-title":"Drug Discov Today"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ebiom.2018.05.008","volume":"32","author":"Kock A.","year":"2018","unstructured":"Kock A.; Larsson K.; Bergqvist F.; Eissler N.; Elfman L.H.M.; Raouf J.; Korotkova M.; Johnsen J.I.; Jakobsson P.J.; Kogner P.; Inhibition of microsomal prostaglandin E synthase-1 in cancer-associated fibroblasts suppresses neuroblastoma tumor growth. EBioMedicine 2018,32,84-92","journal-title":"EBioMedicine"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1073\/pnas.1424355112","volume":"112","author":"Larsson K.","year":"2015","unstructured":"Larsson K.; Kock A.; Idborg H.; Henriksson M.A.; Martinsson T.; Johnsen J.I.; Korotkova M.; Kogner P.; Jakobsson P.J.; COX\/MPGES-1\/PGE pathway depicts an inflammatory dependent high risk neuroblastoma subset. Proc Natl Acad Sci USA 2015,112(26),8070-8075","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","volume":"55","author":"Wang D.","year":"2006","unstructured":"Wang D.; DuBois R.N.; Prostaglandins and cancer. Gut 2006,55(1),115-122","journal-title":"Gut"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"Wang D.","year":"2010","unstructured":"Wang D.; Dubois R.N.; Eicosanoids and cancer. Nat Rev Cancer 2010,10(3),181-193","journal-title":"Nat Rev Cancer"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2010.03.043","volume":"636","author":"Zhang F.","year":"2010","unstructured":"Zhang F.; Liu J.; Shi J.S.; Anti-inflammatory activities of resveratrol in the brain: Role of resveratrol in microglial activation. Eur J Pharmacol 2010,636(1-3),1-7","journal-title":"Eur J Pharmacol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jchemneu.2017.03.003","volume":"87","author":"Terzi M.","year":"2018","unstructured":"Terzi M.; Altun G.; \u015eena S.; Kocaman A.; Kaplan A.A.; Yurt K.K.; Kaplan S.; The use of non-steroidal anti-inflammatory drugs in neurological diseases. J Chem Neuroanat 2018,87,12-24","journal-title":"J Chem Neuroanat"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neuint.2012.12.007","volume":"62","author":"Takeuchi C.","year":"2013","unstructured":"Takeuchi C.; Matsumoto Y.; Kohyama K.; Uematsu S.; Akira S.; Yamagata K.; Takemiya T.; Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis. Neurochem Int 2013,62(3),271-280","journal-title":"Neurochem Int"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jnr.23217","volume":"91","author":"Akitake Y.","year":"2013","unstructured":"Akitake Y.; Nakatani Y.; Kamei D.; Hosokawa M.; Akatsu H.; Uematsu S.; Akira S.; Kudo I.; Hara S.; Takahashi M.; Microsomal prostaglandin E synthase-1 is induced in Alzheimer\u2019s disease and it\u2019s deletion mitigates Alzheimer\u2019s disease like pathology in a mouse model. J Neurosci Res 2013,91(7),909-919","journal-title":"J Neurosci Res"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1073\/pnas.1401797111","volume":"111","author":"Chen L.","year":"2014","unstructured":"Chen L.; Yang G.; Monslow J.; Todd L.; Cormodec D.P.; Tang J.; Grant G.R.; DeLong J.H.; Tang S.Y.; Lawson J.A.; Pure E.; FitzGerald G.A.; Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice. Proc Natl Acad Sci USA 2014,111(18),6828-6833","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2492\/inflammregen.30.26","volume":"30","author":"Matsuo Y.I.","year":"2010","unstructured":"Matsuo Y.I.; Microsomal prostaglandin E synthase-1 is involved in the brain ischemic injury. Inflamm Regen 2010,30(1),26-33","journal-title":"Inflamm Regen"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/pr.2012.119","volume":"72","author":"Siljehav V.","year":"2012","unstructured":"Siljehav V.; Hofstetter A.O.; Jakobsson P.J.; Herlenius E.; mPGES-1 and prostaglandin E2: Vital role in inflammation, hypoxic response, and survival. Pediatr Res 2012,72(5),460-467","journal-title":"Pediatr Res"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bone.2011.10.008","volume":"51","author":"Pelletier J.M.","year":"2012","unstructured":"Pelletier J.M.; Wildi L.M.; Pelletier J.P.; Future therapeutics for osteoarthritis. Bone 2012,51(2),297-311","journal-title":"Bone"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.joca.2008.04.022","volume":"16","author":"Soria M.A.A.","year":"2008","unstructured":"Soria M.A.A.; Beaumont G.H.; Rubio J.M.; Calvo E.; Santillana J.; Egido J.; Largo R.; Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis. Osteoarthritis Cartilage 2008,16(12),1484-1493","journal-title":"Osteoarthritis Cartilage"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.ajpath.2010.12.048","volume":"178","author":"Bage T.","year":"2011","unstructured":"Bage T.; Kats A.; Lopez B.S.; Morgan G.; Nilsson G.; Burt I.; Korotkova M.; Corbett L.; Knox A.J.; Pino L.; Jakobsson P.J.; Modeer T.; Lindberg T.Y.; Expression of Prostaglangin E synthases in periodontitis. Immunolocalisation and cellular regulation. Am J Pathol 2011,178(4),1676-1688","journal-title":"Am J Pathol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.bcp.2010.01.003","volume":"79","author":"Mbalaviele G.","year":"2010","unstructured":"Mbalaviele G.; Pauley A.M.; Shaffer A.F.; Zweifel B.S.; Mathialagan S.; Mnich S.J.; Nemirovskiy O.V.; Carter J.; Gierse J.K.; Wang J.L.; Vazquez M.L.; Moore W.M.; Masferrer J.L.; Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor. Biochem Pharmacol 2010,79(10),1445-1454","journal-title":"Biochem Pharmacol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bmcl.2015.11.024","volume":"26","author":"Kim M.","year":"2016","unstructured":"Kim M.; Lee S.; Park E.B.; Kim K.J.; Lee H.H.; Shin J.S.; Fischer K.; Koeberle A.; Werz O.; Lee K.T.; Lee J.Y.; Hit-to-lead optimization of phenylsulfonyl hydrazides for a potent suppressor of PGE2 production: Synthesis, biological activity, and molecular docking study. Bioorg Med Chem Lett 2016,26(1),94-99","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1016\/j.bmc.2013.10.006","volume":"21","author":"Hanke T.","year":"2013","unstructured":"Hanke T.; R\u00f6rsch F.; Thieme T.M.; Ferreiros N.; Schneider G.; Geisslinger G.; Proschak E.; Gr\u00f6sch S.; Zsilavecz M.S.; Synthesis and pharmacological characterization of benzenesulfonamides as dual species inhibitors of human and murine mPGES-1. Bioorg Med Chem 2013,21(24),7874-7883","journal-title":"Bioorg Med Chem"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/926968","volume":"2012","author":"Dorris S.L.","year":"2012","unstructured":"Dorris S.L.; Peebles R.S.; PGI as a regulator of inflammatory diseases. Mediators Inflamm 2012,2012,1-9","journal-title":"Mediators Inflamm"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cpt.260","volume":"99","author":"Jin Y.","year":"2016","unstructured":"Jin Y.; Smith C.L.; Hu L.; Campanale K.M.; Stoltz R.; Huffman L.G.; McNearney T.A.; Yang X.Y.; Ackermann B.L.; Dean R.; Regev A.; Landschulz W.; Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin E synthase 1 inhibitor, with celecoxib. Clin Pharmacol Ther 2016,99(3),274-284","journal-title":"Clin Pharmacol Ther"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/acs.jmedchem.7b01806","volume":"61","author":"Norman B.H.","year":"2018","unstructured":"Norman B.H.; Fisher M.J.; Schiffler M.A.; Kuklish S.L.; Hughes N.E.; Czeskis B.A.; Cassidy K.C.; Abraham T.L.; Alberts J.J.; Atlas D.L.; Identification and mitigation of reactive metabolites of 2-aminoimidazole-containing microsomal prostaglandin E synthase-1 inhibitors terminated due to clinical drug-induced liver injury. J Med Chem 2018,61(5),2041-2051","journal-title":"J Med Chem"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcp.13423","volume":"84","author":"Jin Y.","year":"2018","unstructured":"Jin Y.; Regev A.; Kam J.; Phipps K.; Smith C.; Henck J.; Campanale K.; Hu L.; Hall D.G.; Yang X.Y.; Nakano M.; McNearney T.A.; Uetrecht J.; Landschulz W.; Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor. Br J Clin Pharmacol 2018,84(1),179-188","journal-title":"Br J Clin Pharmacol"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.prostaglandins.2013.09.001","volume":"107","author":"Leclerc P.","year":"2013","unstructured":"Leclerc P.; Idborg H.; Spahiud L.; Larsson C.; Nekhotiaeva N.; Wannberg J.; Stenberg P.; Korotkova M.; Jakobsson J.; Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation. Prostaglandins Other Lipid Mediat 2013,107,26-34","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2013.03.005","volume":"102-103","author":"Leclerc P.","year":"2013","unstructured":"Leclerc P.; Pawelzik S.C.; Idborg H.; Spahiu L.; Larsson C.; Stenberg P.; Korotkova M.; Jakobsson P.J.; Characterization of a new mPGES-1 inhibitor in rat models of inflammation. Prostaglandins Other Lipid Mediat 2013,102-103,1-12","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1016\/j.bmcl.2017.06.075","volume":"27","author":"Zhou Z.","year":"2017","unstructured":"Zhou Z.; Yuan Y.; Zhou S.; Ding K.; Zheng F.; Zhan C.G.; Selective inhibitors of human mPGES-1 from structure-based computational screening. Bioorg Med Chem Lett 2017,27(16),3739-3743","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.bmc.2011.08.040","volume":"19","author":"Hamza A.","year":"2011","unstructured":"Hamza A.; Zhao X.; Tong M.; Tai H.H.; Zhan C.G.; Novel human mPGES-1 inhibitors identified through structure-based virtual screening. Bioorg Med Chem 2011,19(20),6077-6086","journal-title":"Bioorg Med Chem"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejmech.2016.09.042","volume":"125","author":"Lauro G.","year":"2017","unstructured":"Lauro G.; Manfra M.; Pedatella S.; Fischer K.; Cantone V.; Terracciano S.; Bertamino A.; Ostacolo C.; Monterrey I.G.; Nisco M.D.; Riccio R.; Novellino E.; Werz O.; Campiglia P.; Bifulco G.; Identification of novel microsomal prostaglandin E2 synthase-1(mPGES-1) lead inhibitors from fragment virtual screening. Eur J Med Chem 2017,125,278-287","journal-title":"Eur J Med Chem"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1021\/acs.jmedchem.5b00330","volume":"58","author":"Luz J.G.","year":"2015","unstructured":"Luz J.G.; Antonysamy S.; Kuklish S.L.; Condon B.; Lee M.R.; Allison D.; Yu X.P.; Chandrasekhar S.; Backer R.; Zhang A.; Russell M.; Chang S.S.; Harvey A.; Sloan A.V.; Fisher M.J.; Crystal structures of mPGES-1 inhibitor complexes form a basis for the rational design of potent analgesic and anti-inflammatory therapeutics. J Med Chem 2015,58(11),4727-4737","journal-title":"J Med Chem"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.ejmech.2017.10.039","volume":"143","author":"Micco S.D.","year":"2018","unstructured":"Micco S.D.; Terracciano S.; Cantone V.; Fischer K.; Koeberle A.; Foglia A.; Riccio R.; Werz O.; Bruno I.; Bifulco G.; Discovery of new potent molecular entities able to inhibit mPGES-1. Eur J Med Chem 2018,143,1419-1427","journal-title":"Eur J Med Chem"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bmcl.2012.11.019","volume":"23","author":"Lee K.","year":"2013","unstructured":"Lee K.; Pham V.C.; Choi M.J.; Kim K.J.; Lee K.T.; Han S.G.; Yu Y.G.; Lee J.Y.; Fragment-based discovery of novel and selective mPGES-1 inhibitors Part1: Identification of sulfonamido-1,2,3-triazole-4,5-dicarboxylic acid. Bioorg Med Chem Lett 2013,23(1),75-80","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.bmcl.2005.05.027","volume":"15","author":"Riendeau D.","year":"2005","unstructured":"Riendeau D.; Aspiotis R.; Ethier D.; Gareau Y.; Grimm E.L.; Guay J.; Guiral S.; Juteau H.; Mancini J.A.; Methot N.; Rubin J.; Friesen R.W.; Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886. Bioorg Med Chem Lett 2005,15(14),3352-3355","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.bmcl.2007.10.033","volume":"17","author":"Cote B.","year":"2007","unstructured":"Cote B.; Boulet L.; Brideau C.; Claveau D.; Ethier D.; Frenette R.; Gagnon M.; Giroux A.; Guay J.; Guiral S.; Mancini J.; Martins E.; Masse F.; Methot N.; Riendeau D.; Rubin J.; Xu D.; Yu H.; Ducharme Y.; Friesen R.W.; Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors. Bioorg Med Chem Lett 2007,17(24),6816-6820","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/jpet.108.138776","volume":"326","author":"Xu D.","year":"2008","unstructured":"Xu D.; Rowland S.E.; Clark P.; Giroux A.; Bernard C.B.; Guiral S.; Salem M.; Ducharme Y.; Friesen R.W.; Methot N.; Mancini J.; Audoly L.; Riendeau D.; MF63 [2-(6-Chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor. Relieves pyresis and pain in preclinical models of inflammation. J Pharmacol Exp Ther 2008,326(3),754-763","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1158\/1535-7163.MCT-09-0290","volume":"8","author":"Koeberle A.","year":"2009","unstructured":"Koeberle A.; Northoff H.; Werz O.; Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1. Mol Cancer Ther 2009,8(8),2348-2355","journal-title":"Mol Cancer Ther"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bbrc.2009.08.005","volume":"388","author":"Koeberle A.","year":"2009","unstructured":"Koeberle A.; Bauer J.; Verhoff M.; Hoffmann M.; Northoff H.; Werz O.; Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E2 synthase-1. Biochem Biophys Res Commun 2009,388(2),350-354","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/jpet.112.193847","volume":"342","author":"Bauer J.","year":"2012","unstructured":"Bauer J.; Kuehnl S.; Rollinger J.M.; Scherer O.; Northoff H.; Stuppner H.; Werz O.; Koeberle A.; Carnosol and carnosic acids from Salvia officinalis inhibit microsomal prostaglandin E2 synthase-1. J Pharmacol Exp Ther 2012,342,169-176","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bcp.2017.07.010","volume":"142","author":"Zhou H.","year":"2017","unstructured":"Zhou H.; Liu J.X.; Luo J.F.; Cheng C.S.; Leung E.L.H.; Li Y.; Hui X.; Liu Z.Q.; Chen T.B.; Duan F.G.; Dong Y.; Zuo Y.H.; Li C.; Lio C.K.; Li T.; Luo P.; Xie Y.; Yao X.J.; Wange P.X.; Liu L.; Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis. Biochem Pharmacol 2017,142,133-144","journal-title":"Biochem Pharmacol"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1016\/j.bmc.2015.05.045","volume":"23","author":"Noha S.M.","year":"2015","unstructured":"Noha S.M.; Fischer K.; Koeberle A.; Garscha U.; Werz O.; Schuster D.; Discovery of novel, non-acidic mPGES-1 inhibitorsby virtual screening with a multistep protocol. Bioorg Med Chem 2015,23(15),4839-4845","journal-title":"Bioorg Med Chem"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1016\/j.bmcl.2016.10.079","volume":"26","author":"Muthukaman N.","year":"2016","unstructured":"Muthukaman N.; Deshmukh S.; Sarode N.; Tondlekar S.; Tambe M.; Pisal D.; Shaikh M.; Kattige V.G.; Honnegowda S.; Karande V.; Kulkarni A.; Jadhav S.B.; Mahat M.Y.A.; Gudi G.S.; Joshi N.K.; Gharat L.A.; Discovery of 2-((2-chloro -6- fluorophenyl) amino) -N- (3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4] dioxino [20,30:3,4] benzo [1,2-d] imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor. Bioorg Med Chem Lett 2016,26(24),5977-5984","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1016\/j.bmcl.2017.10.062","volume":"27","author":"Muthukaman N.","year":"2017","unstructured":"Muthukaman N.; Tambe M.; Deshmukh S.; Pisal D.; Tondlekar S.; Shaikh M.; Sarode N.; Kattige V.G.; Pisat M.P.; Sawant P.; Honnegowda S.; Karande V.; Kulkarni A.; Behera D.; Jadhav S.B.; Sangana R.R.; Gudi G.S.; Joshi N.K.; Gharat L.A.; Discovery of furan and dihydrofuran-fused tricyclic benzo[d]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1. Bioorg Med Chem Lett 2017,27(23),5131-5138","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bmcl.2018.02.048","volume":"28","author":"Muthukaman N.","year":"2018","unstructured":"Muthukaman N.; Deshmukh S.; Tambe M.; Pisal D.; Tondlekar S.; Shaikh M.; Sarode N.; Kattige V.G.; Sawant P.; Pisat M.; Karande V.; Honnegowda S.; Kulkarni A.; Behera B.; Jadhav S.B.; Sangana R.R.; Gudi G.S.; Joshi N.K.; Gharat L.A.; Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series - Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2. Bioorg Med Chem Lett 2018,28(7),1211-1218","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bmcl.2011.11.015","volume":"22","author":"Shiro T.","year":"2012","unstructured":"Shiro T.; Takahashi H.; Kakiguchi K.; Inoue Y.; Masuda K.; Nagata H.; Tobe M.; Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E2 synthase-1 inhibitors. Bioorg Med Chem Lett 2012,22(1),285-288","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bmcl.2012.10.040","volume":"23","author":"Kablaoui N.","year":"2013","unstructured":"Kablaoui N.; Patel S.; Sharo J.; Meian D.; Hoffmaster K.; Berlioz F.; Vazqurez M.L.; Moore W.M.; Nugent R.A.; Novel benzoxazole inhibitors of MPGES-1. Bioorg Med Chem Lett 2013,23(3),907-911","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1096\/fj.12-214445","volume":"27","author":"Kats A.","year":"2017","unstructured":"Kats A.; Bage T.; Georgsson P.; Jonsson J.; Quezada H.C.; Gustaffson A.; Jansson L.; Lindberg C.; Nasstrom K.; Lindberg T.Y.; Inhibition of microsomal prostaglandin Esynthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and amerolites experimental periodontitis in vivo. FASEB J 2017,27(6),2328-2341","journal-title":"FASEB J"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1471-4159.2012.07771.x","volume":"122","author":"Shin J.H.","year":"2012","unstructured":"Shin J.H.; Lee Y.A.; Lee J.K.; Lee Y.B.; Cho W.; Im D.S.; Lee J.H.; Yun B.S.; Springer J.E.; Gwag B.J.; Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a Mouse model of amyotropic lateral sclerosis. J Neurochem 2012,122(5),952-961","journal-title":"J Neurochem"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1016\/j.bmcl.2014.08.056","volume":"24","author":"Banerjee A.","year":"2014","unstructured":"Banerjee A.; Pawar M.Y.; Patil S.; Yadav P.S.; Kadam P.A.; Kattige V.G.; Deshpande D.S.; Pednekar P.; Pisat M.K.; Gharat L.A.; Development of 2-aryl substituted quinazolin-4(3H)-one,pyrido[4,3-d]pyrimidin-4(3H)-one and pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as microsomal prostaglandin E2 synthase-1 inhibitors. Bioorg Med Chem Lett 2014,24(20),4838-4844","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bmc.2016.01.002","volume":"24","author":"Micco S.D.","year":"2016","unstructured":"Micco S.D.; Spatafora C.; Cardullo N.; Riccio R.; Fischer K.; Pergola C.; Koeberle A.; Werz O.; Chalal M.; Fasseur D.V.; Tringali C.; Bifulco G.; 2,3-Dihydrobenzofuran privileged structures as new bioinspired lead compounds for the design of mPGES-1 inhibitors. Bioorg Med Chem 2016,24(4),820-826","journal-title":"Bioorg Med Chem"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/jpet.108.139444","volume":"326","author":"Koeberle A.","year":"2008","unstructured":"Koeberle A.; Siemoneit U.; B\u00fchring U.; Northoff H.; Laufer S.; Albrecht W.; Werz O.; Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1. J Pharmacol Exp Ther 2008,326(3),975-982","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/ard.62.6.501","volume":"62","author":"Pelletier J.M.","year":"2003","unstructured":"Pelletier J.M.; Lajeunesse D.; Reboul P.; Pelletier J.P.; Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 2003,62(6),501-509","journal-title":"Ann Rheum Dis"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ejmech.2018.03.045","volume":"150","author":"G\u00fcr Z.T.","year":"2018","unstructured":"G\u00fcr Z.T.; \u00c7al\u0131skan B.; Garscha U.; Olga\u00e7 A.; Schubert U.S.; Gerstmeier J.; Werz O.; Banoglu E.; Identification of multi-target inhibitors of leukotriene and prostaglandin E2 biosynthesis by structural tuning of the FLAP inhibitor BRP-7. Eur J Med Chem 2018,150,876-899","journal-title":"Eur J Med Chem"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T14:43:14Z","timestamp":1574433794000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170266\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10,24]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520619666190227174137","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}